ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - Italy 

Ranking results:

Past rankings:

2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:900-1000
Total Number of Projects:69
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:37
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:700-800
Total Project Funding:600-700
Networking Rank (Reputation):900-1000
Partner Constancy:300-400
Project Leadership Index:800-900
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:700-800
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:800-900
Project Leadership Index:700-800
Diversity Index:600-700
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:900-1000
Project Leadership Index:900-1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Total Project Funding:600-700
Networking Rank (Reputation):> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 14
As coordinator: 1
As participant: 12
Sole participant: 1
Coordinator / Participant Ratio: 0.08*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2016 0 13.136.218 1.522.500 2
2013 0 8.497.408 2.677.088 2
2012 0 16.979.480 307.205 3
2011 123.600 20.918.035 1.318.100 2 3
2010 0 8.998.890 306.554 2

Networking:

Partners:

Institution:Projects [No]:
DEUTSCHES KREBSFORSCHUNGSZENTRUM4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD4
INSTITUT GUSTAVE ROUSSY3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE3
ACADEMISCH ZIEKENHUIS LEIDEN2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE2
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER2
KAROLINSKA INSTITUTE2
RUPRECHT KARLS UNIVERSITAET HEIDELBERG2
STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC2
THE CHRISTIE NHS FOUNDATION TRUST2
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA2
UNIVERSITAET BAYREUTH2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITEIT GENT2
ALLINIMAGE1
ASOCIACION INSTITUTO BIODONOSTIA1
ASSOCIAZIONE IBLEA PER LA RICERCA EPIDEMIOLOGICA ONLUS1
ATHENS TECHNOLOGY CENTER1
AZIENDA OSPEDALIEROUNIVERSITARIA DI PARMA1
BRAINSHAKE OY1
CENTRUM ONKOLOGII INSTYTUT IM MARII SKLODOWSKIECURIE1
CONSEJERIA DE SALUD Y SERVICIOS SANITARIOS PRINCIPADO DE ASTURIAS1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
COPENHAGEN BUSINESS SCHOOL1
DANISH CANCER SOCIETY1
DEUTSCHES INSTITUT FUER ERNAEHRUNGSFORSCHUNG1
DIAGENODE1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ECANCERMEDICALSCIENCE1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ESAOTE1
ESCUELA ANDALUZA DE SALUD PUBLICA1
EUROPEAN CANCER ORGANISATION1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EVONIK NUTRITION & CARE1
FOUNDATION FOR GENOMICS & POPULATION HEALTH1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUDAN UNIVERSITY SHANGHAI CANCER CENTER1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
FUNDACION DE INVESTIGACION DEL CANCER DE LA UNIVERSIDAD DE SALAMANCA1
FUNDACION DE LA SOCIEDAD ESPANOLA DE LA ONCOLOGIA MEDICA1
FUNDACION INSTITUTO VALENCIANO DE ONCOLOGIA1
FUNDACION PARA LA FORMACION E INVESTIGACION SANITARIAS DE LA REGION DE MURCIA1
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA1
FUNDACION PUBLICA GALEGA DE MEDICINA XENOMICA1
FUNDACION PUBLICA MIGUEL SERVET1
GOETEBORGS UNIVERSITET1
GROUPEMENT EUROPEEN D INTERET ECONOMIQUE ORGANISATION OF EUROPEAN CANCER INSTITUTES OECI1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
HELLENIC HEALTH FOUNDATION1
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG1
HOSPITAL UNIVERSITARIO SON ESPASES1
HUMAN GENETICS FOUNDATION1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INSTITUT BERGONIE1
INSTITUT CURIE1
INSTITUT JULES BORDET1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUT REGIONAL DU CANCER DE MONTPELLIER1
INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL1
INSTITUTE OF MACROMOLECULAR CHEMISTRY ACADEMY OF SCIENCES OF THE CZECH REPUBLIC1
INSTITUTO TUMORI GIOVANNI PAOLO II1
IOX THERAPEUTICS LIMITED1
ISTITUTO EUROPEO DI ONCOLOGIA1
ISTITUTO ORTOPEDICO RIZZOLI1
ISTITUTO PER LO STUDIO E LA PREVENZIONE ONCOLOGICA1
ITEOS THERAPEUTICS1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KLINIKUM DER UNIVERSITAET ZU KOELN1
KRZYSZTOF KUCHARCZYK TECHNIKI ELEKTROFORETYCZNE SPZOO1
KUNGLIGA TEKNISKA HOEGSKOLAN1
LANCASTER UNIVERSITY1
LEIBNIZINSTITUT FUER PRAEVENTIONSFORSCHUNG UND EPIDEMIOLOGIE BIPS1
LUNDS UNIVERSITET1
LYON INGENIERIE PROJETS1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MEDICAL RESEARCH COUNCIL1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MINERVA PUBLIC RELATIONS & COMMUNICATIONS LIMITED1
MRC HOLLAND BV1
MULTIMED ENGINEERS1
NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT1
ONCOARENDI THERAPEUTICS SPOLKA AKCYJNA1
ORGANISMO AUTONOMO INSTITUTO DE SALUD PUBLICA Y LABORAL DE NAVARRA1
ORSZAGOS ONKOLOGIAI INTEZET1
OSLO UNIVERSITETSSYKEHUS HF1
OXFORD GENE TECHNOLOGY1
PECSI TUDOMANYEGYETEM UNIVERSITY OF PECS1
POLITECNICO DI MILANO1
RAND EUROPE COMMUNITY INTEREST COMPANY1
REGIONE VENETO AZIENDA U L S S N 9 DI TREVISO1
RESEARCH & EDUCATION INSTITUTE OF CHILD HEALTH1
RIJKSINSTITUUT VOOR VOLKSGEZONDHEIDEN MILIEUNATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT1
SARCOMA PATIENTS EURONET EV1

Constancy:

Total number of partners: 159
Partner loyalty:
Frequent Partner: (> 2 projects): 14
Rare Partner: 145
Frequent / Rare Partner Ratio: 0.1

Project overview:

Start dateProjectacronymrolefundingpartners
2016-05-01Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy PRECIOUSparticipant8.291.21811
2016-01-01Big Data and models for personalized Head and Neck Cancer Decision support BD2Decideparticipant4.845.00013
2013-10-01Validating predictive models of radiotherapy toxicity to improve quality-of-life and reduce side-effects in cancer survivors REQUITEparticipant5.997.40815
2013-08-01Randomized controlled trial of metformin and dietary restriction to prevent age-related morbid events in people with metabolic syndrome MEMEMEparticipant2.500.0001
2012-03-01Determinants of eating behaviour in European children, adolescents and their parents I.Familyparticipant9.000.00017
2012-01-01Toward enhancing activities of European institutions in the FDUSCC-IM cancer research joint institute in China IMMUNOCANparticipant1.992.2145
2012-01-01EPIC-CVD: Individualised CVD risk assessment: tailoring targeted and cost-effective approaches to Europe's diverse populations EPIC-CVDparticipant5.987.26630
2011-12-01European Clinical trials in Rare Sarcomas within an integrated translational trial network EUROSARCparticipant5.953.83218
2011-02-01Role and Modulation of Jak and STAT signaling in Graft Rejection and Graft versus Host Disease HSCT and Jak-STATcoordinator75.0001
2011-01-02Transfection Ability and Intracellular Pathway of LbL Nanostructured siRNA Delivery Systems Nanosirnacoordinator48.6003
2011-01-01Determining (epi)genetic therapeutic signatures for improving lung cancer prognosis CURELUNGparticipant2.965.74911
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428
2010-11-01Genomic predictors and oncogenic drivers in hepatocellular carcinoma HEPTROMICparticipant2.999.47810
2010-05-01Three modality contrast imaging using multi-functionalized microballoons 3MICRONparticipant5.999.41210

Alias institution names:

  • ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI